Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chaihuanglidan capsule for chronic cholecystitis (phase III)
CTR20221158Phase 3Completed
- Sponsor
- Yiling Pharmaceutical
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Chaihuang Lidan in chronic cholecystitis, sponsored by Yiling Pharmaceutical. Started May 2022; status: completed.
02
Drugs
Chaihuang Lidan
03
Conditions
chronic cholecystitis
Beyond the preview
Go deeper on CTR20221158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221158.